Healthy women drug study for a new cancer treatment
This trial studies a new experimental drug, called navlimetostat, in healthy women to understand how the body processes and gets rid of it. It is an important early step before the drug can be tested in patients with cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman who cannot become pregnant (either because you have had surgery to remove your uterus or ovaries, or because you have gone through menopause).
- Your body mass index (BMI) must be between 18.0 and 35.0.
- You must have regular bowel movements (at least one every two days) over the past month.
- You must not have any significant ongoing or recent medical illness.
- You must not have any current or recent stomach or intestinal problems.
- You must not have a history of unusual bleeding or easy bruising.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new tablet form of navlimetostat in healthy adult women. The goal is to understand how the body processes this drug and make sure it is safe and well-tolerated.
This trial tests a new drug, Navlimetostat (BMS-986504), for people with advanced solid tumors that have a specific genetic change called MTAP deletion or loss. It looks at safety, side effects, and how the drug works in the body.
This study tests how safe and tolerable a new drug, KSHN001034, is in healthy women who have gone through menopause. It involves multiple doses to see how your body processes the medicine.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This study tests how well and how safely different combinations of cancer drugs work for people with metastatic or inoperable locally advanced breast cancer. It may help by finding a better treatment option and collecting information to guide future care.
This trial tests a new drug called 7MW4911 for people with advanced gastrointestinal cancer that has not responded to standard treatments. The drug is designed to target and attack cancer cells, and doctors will check if it is safe and effective.
Hear when a new Healthy Female Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.